Javier de Diego-Adeliño (Javier De Diego-Adeliño)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Computed Tomography

Spinal Cord Injury

Major Depressive Disorder

Top Venues

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

European archives of psychiatry and clinical neuroscience

Expert opinion on drug safety

European psychiatry : the journal of the Association of European Psychiatrists

This page only lists publications with an associated author ORCID identifier.

Publications

Muriel Vicent-Gil, Joan Trujols, Serra-Blasco M, Guillem Navarra-Ventura, Dolors Puigdemont, Carlo Alemany Santamaria, Sara Crivillés, Javier de Diego-Adeliño, Narcís Cardoner, Maria J Portella
If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression. European psychiatry : the journal of the Association of European Psychiatrists (2023)
Ángel Oteo-Álvaro, Carlos Goicoechea García, Alejandra Inocencio Sánchez, Carlo Alemany Santamaria, Javier de Diego-Adeliño
Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Javier de Diego-Adeliño, José Manuel Crespo, Fernando Mora, Adrián Neyra, Pedro Iborra, Luis Gutiérrez-Rojas, Selman F Salonia
Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert opinion on drug safety 21 (5) (2021)
Mar Carceller-Sindreu, Javier de Diego-Adeliño, Maria J Portella, Xavier Garcia-Moll, Maria Figueras, Aina Fernandez-Vidal, Josep M Queraltó, Dolors Puigdemont, Enric Álvarez
Lack of relationship between plasma levels of escitalopram and QTc-interval length. European archives of psychiatry and clinical neuroscience 267 (8) (2017)